Establishment Labs Holdings Inc. Net Change in Cash
Establishment Labs Holdings Inc. (ESTA) reported Net Change in Cash of -$4.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-07
- Establishment Labs Holdings Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$7.47M.
- Establishment Labs Holdings Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$21.17M, a 164.26% decline year-over-year.
- Establishment Labs Holdings Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $32.95M.
- Establishment Labs Holdings Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$23.51M.
- Establishment Labs Holdings Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$14.78M, a 129.37% decline from fiscal 2024.
- Establishment Labs Holdings Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $50.31M.
- Establishment Labs Holdings Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$26.32M, a 303.40% decline from fiscal 2022.
- Establishment Labs Holdings Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $12.94M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.42M 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | -$7.47M 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | -$14.78M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | -$19.72M 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | -$35.71M 10-Q · filed 2026-08-07 | |||
| 2025-03-31 | -$21.17M 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | $50.31M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | -$338.00K 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | $14.56M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | $32.95M 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | -$26.32M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | -$14.16M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $23.83M 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | -$23.51M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $12.94M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | $11.93M 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | $37.84M 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | -$8.76M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | -$31.11M 10-K · filed 2024-03-04 | |||
| 2021-09-30 | -$19.90M 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | -$7.72M 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | -$6.57M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $46.87M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $43.78M 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $48.73M 10-Q · filed 2021-07-30 | |||
| 2020-03-31 | $55.94M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | -$14.98M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | -$10.08M 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | -$20.77M 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | -$9.50M 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $41.77M 10-K · filed 2020-03-16 | |||
| 2018-09-30 | $54.71M 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $778.00K 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | -$4.25M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |